265
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Comparison of the radiotoxicity of the 99mTc-labeled compounds 99mTc-pertechnetate, 99mTc-HMPAO and 99mTc-MIBI

, , , , &
Pages 698-706 | Received 22 Jul 2015, Accepted 09 Mar 2016, Published online: 27 Apr 2016

References

  • Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. 1998. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med. 39:266–271.
  • Backus M, Piwnica-Worms D, Hockett D, Kronauge J, Lieberman M, Ingram P, LeFurgey A. 1993. Microprobe analysis of Tc-MIBI in heart cells: Calculation of mitochondrial membrane potential. Am J Physiol. 265:C178–187.
  • Balagurumoorthy P, Xu X, Wang K, Adelstein SJ, Kassis AI. 2012. Effect of distance between decaying (125)I and DNA on Auger-electron induced double-strand break yield. Int J Radiat Biol. 88:998–1008.
  • Bewersdorf J, Bennett BT, Knight KL. 2006. H2AX chromatin structures and their response to DNA damage revealed by 4Pi microscopy. Proc Natl Acad Sci USA. 103:18137–18142.
  • Cai Z, Chen Z, Bailey KE, Scollard DA, Reilly RM, Vallis KA. 2008. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. J Nucl Med. 49:1353–1361.
  • Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. 1992. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med. 33:1516–1522.
  • Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. 2003. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol. 5:675–679.
  • Cornelissen B. 2014. Imaging the inside of a tumour: A review of radionuclide imaging and theranostics targeting intracellular epitopes. J Labelled Comp Radiopharm. 57:310–316.
  • Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. 1990. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res. 50:2198–2202.
  • Feinendegen LE. 2012. The Auger effect in biology and medicine. Nuklearmedizin. 51:161–162.
  • Fourré C, Halpern S, Jeusset J, Clerc J, Fragu P. 1992. Significance of secondary ion mass spectrometry microscopy for technetium-99m mapping in leukocytes. J Nucl Med. 33:2162–2166.
  • Freudenberg R, Wendisch M, Runge R, Wunderlich G, Kotzerke J. 2012. Reduction in clonogenic survival of sodium-iodide symporter (NIS)-positive cells following intracellular uptake of (99m)Tc versus (188)Re. Int J Radiat Biol. 88:991–997.
  • Freudenberg R, Runge R, Maucksch U, Berger V, Kotzerke J. 2014. On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and (123)I. Med Phys. 41:062503.
  • Galluzzi L, Bravo-San Pedro JM, Kroemer G. 2014. Organelle-specific initiation of cell death. Nat Cell Biol. 16:728–736.
  • Georgakilas AG, O’Neill P, Stewart RD. 2013. Induction and repair of clustered DNA lesions: what do we know so far? Radiat Res. 180:100–109.
  • Haefliger P, Agorastos N, Renard A, Giambonini-Brugnoli G, Marty C, Alberto R. 2005. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+. Bioconjug Chem. 16:582–587.
  • Hershman JM, Okunyan A, Rivina Y, Cannon S, Hogen V. 2011. Prevention of DNA double-strand breaks induced by radioiodide-(131)I in FRTL-5 thyroid cells. Endocrinology. 152:1130–1135.
  • Howell RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 19:1371–1383.
  • Howell RW. 2008. Auger processes in the 21st century. Int J Radiat Biol. 84:959–975.
  • Kahmann C, Wunderlich G, Freudenberg R, Zophel K, Oehme L, Kotzerke J. 2010. Radioprotection of thyroid cells mediated by methimazole. Int J Radiat Biol. 86:811–816.
  • Kassis AI. 2008. Therapeutic radionuclides: Biophysical and radiobiologic principles. Semin Nucl Med. 38:358–366.
  • Kassis AI, Fayad F, Kinsey BM, Sastry KS, Taube RA, Adelstein SJ. 1987. Radiotoxicity of 125I in mammalian cells. Radiat Res. 111: 305–318.
  • Kotzerke J, Punzet R, Runge R, Ferl S, Oehme L, Wunderlich G, Freudenberg R. 2014. 99mTc-labeled HYNIC-DAPI causes plasmid DNA damage with high efficiency. PLoS One. 9:e104653.
  • Kriehuber R, Kadenbach K, Schultz F, Weiss DG. 2004. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc. Int J Radiat Biol. 80:875–880.
  • Leonard JP, Nowotnik DP, Neirinckx RD. 1986. Technetium-99m-d, 1-HM-PAO: A new radiopharmaceutical for imaging regional brain perfusion using SPECT – a comparison with iodine-123HIPDM. J Nucl Med. 27:1819–1823.
  • Löbrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. 2010. gammaH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization. Cell Cycle. 9:662–669.
  • Narra VR, Sastry KS, Goddu SM, Howell RW, Strand SE, Rao DV. 1994. Relative biological effectiveness of 99mTc radiopharmaceuticals. Med Phys. 21:1921–1926.
  • Neumaier T, Swenson J, Pham C, Polyzos A, Lo AT, Yang P, Dyball J, Asaithamby A, Chen DJ, Bissell MJ, et al. 2012. Evidence for formation of DNA repair centers and dose-response nonlinearity in human cells. Proc Natl Acad Sci USA. 109:443–448.
  • Paillas S, Boudousq V, Piron B, Kersual N, Bardies M, Chouin N, Bascoul-Mollevi C, Arnaud FX, Pelegrin A, Navarro-Teulon I, et al. 2013. Apoptosis and p53 are not involved in the anti-tumor efficacy of (1)(2)(5)I-labeled monoclonal antibodies targeting the cell membrane. Nucl Med Biol. 40:471–480.
  • Pedraza-Lopez M, Ferro-Flores G, Mendiola-Cruz MT, Morales-Ramirez P. 2000. Assessment of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. Mutat Res. 465:139–144.
  • Piron B, Paillas S, Boudousq V, Pelegrin A, Bascoul-Mollevi C, Chouin N, Navarro-Teulon I, Pouget JP. 2014. DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy. Nucl Med Biol. 41(Suppl.):e75–e83.
  • Piwnica-Worms DP, Kronauge JF, LeFurgey A, Backus M, Hockett D, Ingram P, Lieberman M, Holman BL, Jones AG, Davison A. 1994. Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging. 12:641–652.
  • Pouget JP, Santoro L, Raymond L, Chouin N, Bardies M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pelegrin M, et al. 2008. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res. 170:192–200.
  • Rothkamm K, Horn S. 2009. gamma-H2AX as protein biomarker for radiation exposure. Ann Ist Super Sanita. 45:265–271.
  • Rothkamm K, Kruger I, Thompson LH, Löbrich M. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 23:5706–5715.
  • Rothkamm K, Barnard S, Moquet J, Ellender M, Rana Z, Burdak-Rothkamm S. 2015. DNA damage foci: Meaning and significance. Environ Mol Mutagen. 56:491–504.
  • Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pelegrin M, Navarro-Teulon I, Pelegrin A, Pouget JP. 2009. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. J Nucl Med. 50:2033–2041.
  • Santos-Cuevas CL, Ferro-Flores G, Rojas-Calderon EL, Garcia-Becerra R, Ordaz-Rosado D, Arteaga de Murphy C, Pedraza-Lopez M. 2011. 99mTc-N2S2-Tat (49-57)-bombesin internalized in nuclei of prostate and breast cancer cells: Kinetics, dosimetry and effect on cellular proliferation. Nucl Med Commun. 32:303–313.
  • Sasaki T, Fujibayashi Y, Senda M. 1998. Distribution of glutathione and technetium-99m-meso-HMPAO in normal and diethyl maleate-treated mouse brain mitochondria. J Nucl Med. 39:2178–2183.
  • Schipper ML, Riese CG, Seitz S, Weber A, Behe M, Schurrat T, Schramm N, Keil B, Alfke H, Behr TM. 2007. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. Eur J Nucl Med Mol Imaging. 34:638–650.
  • Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J. 2003. Anion selectivity by the sodium iodide symporter. Endocrinology. 144:247–252.
  • Vitor RF, Esteves T, Marques F, Raposinho P, Paulo A, Rodrigues S, Rueff J, Casimiro S, Costa L, Santos I. 2009. (99m)Tc-tricarbonyl complexes functionalized with anthracenyl fragments: Synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cells. Cancer Biother Radiopharm. 24:551–563.
  • Wendisch M, Drechsel J, Freudenberg R, Runge R, Wunderlich G, Kotzerke J. 2009. [Cellular damage in vitro]. Nuklearmedizin. 48:208–214.
  • Yasui LS, Hofer KG. 1986. Role of mitochondrial DNA in cell death induced by 125I decay. Int J Radiat Biol Relat Stud Phys Chem Med. 49:601–610.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.